Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy

Transplantation

Volumn 83, Issue 12, 2007, Pages 1563-1570

  Ellis, Demetrius ^a   Shapiro, Ron ^b   Moritz, Michael ^a   Vats, Abhay ^a   Basu, Amit ^b   Tan, Henkie ^b   Kayler, Liise ^b   Janosky, Janine ^b   Starzl, Thomas E ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alemtuzumab; Antithymocyte globulin; Children; Kidney transplantation; Steroid avoidance; Tacrolimus

Indexed keywords

ACETYLSALICYLIC ACID; ALEMTUZUMAB; CALCINEURIN INHIBITOR; COTRIMOXAZOLE; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NYSTATIN; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE CELLULAR REJECTION; ACUTE GRAFT REJECTION; ACUTE PANCREATITIS; ADOLESCENT; ADULT; ANEMIA; ARTICLE; ASCITES; AUTOIMMUNE HEMOLYTIC ANEMIA; CELLULITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE SYNDROME; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERANCE; FEEDING DISORDER; FEMALE; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HEMATURIA; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE OBSTRUCTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; METABOLIC ACIDOSIS; MONOTHERAPY; NEPHROTOXICITY; NEUTROPENIA; OTITIS MEDIA; PATIENT COMPLIANCE; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; PYURIA; SCORING SYSTEM; SEPSIS; WOUND INFECTION;

ADOLESCENT; ANEMIA; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CREATININE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTRAOPERATIVE CARE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; POSTOPERATIVE COMPLICATIONS; TACROLIMUS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 34250874482     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000266576.01935.ea     Document Type: Article

References (37)

1. Meier-Kriesche H-U, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
2. Kreis HA, Ponticelli C. Causes of late renal allograft loss: Chronic allograft dysfunction, death and other factors. Transplantation 2001; 72: SS5.
3. Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923.
4. Ivanyi B. Transplant capillaropathy and transplant glomerulopathy: Ultrastructural markers of chronic renal allograft rejection. Nephrol Dial Transplant 2003; 18: 655.
5. Nankivell BJ, Burrows RJ, Fung CL, et al. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004; 78: 557.
6. Knechtle SJ, Pirsch JD, H Fechner J Jr, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003; 3: 722.
7. Kirk AD, Hale DA, Mannon RB, et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003; 76: 120.
8. Calne R, Moffatt SD, Friend PJ, et al. Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999; 68: 1613.
9. Vathsala A, Ona ET, Tan SY, Suresh S, et al. Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation. Transplantation 2005; 80: 765.
10. Shapiro R, Jordan M, Basu A, et al. Kidney transplantation under a tolerogenic regimen of recipient pre-treatment and low-dose postoperative immunosuppression, with subsequent weaning. Ann Surg 2003; 238: 520.
11. Agha IA, Rueda J, Alvarez A, et al. Short course induction immunosuppression with Thymoglobulin for renal transplant recipients. Transplantation 2002; 73: 473.
12. Ciancio G, Burke G, Gaynor J, et al. The use of Campath-1H as induction therapy in renal transplantation: Preliminary results. Transplantation 2004; 78: 426.
13. Hale G, Dyer MJ, Clark MR, et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody of Campath 1H. Lancet 1998; 2: 1394.
14. Fierro A, Mora JR, Bono MR, et al. Dendritic cells and the mode of action of anticalcineurinic drugs: An integrating hypothesis. Nephrol Dial Transplant 2003; 18: 467.
15. Billingham RE, Brent L, Medawar PB. Activity acquired tolerance of foreign cells. Nature 1953; 172: 603.
16. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1502.
17. Calne Sir Roy. Prope tolerance: The future of organ transplantation - from the laboratory to the clinic. Transplantation 2004; 77: 930.
18. Ault BH, Honaker MR, Gaber AO, et al. Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients. Pediatr Nephrol 2002; 17: 815.
19. Bartosh SM, Knechtle SJ, Sollinger HW. Campath-1H use in pediatric renal transplantation. Am J Transplant 2005; 5: 1569.
20. Shapiro R, Ellis D, Tan HP, et al. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006; 148: 813.
21. Ellis D, Gilboa N, Bellinger M, Shapiro R. Renal transplantation in infants and children. In: Renal Transplantation. Shapiro R, Simmons RL, Starzl TE, eds. New York: Appleton & Lange, 1997:427-469.
22. Rebello P, Cwynarski K, Varughese M, et al. Pharmacokinetics of CAMPATH-1H in BMT patients. Cytotherapy 2001; 3: 261.
23. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 1987; 34: 571.
24. Ellis D. Growth and renal function after steroid-free tacrolimus-based immunousppression in children with renal transplants. Pediatr Nephrol 2000; 14: 689.
25. Worthington JE, Martin S, Al-Husseini DM, et al. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplanation 2003; 75: 1034.
26. Cai J, Terasaki PI, Bloom DD, et al. Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolumus monotherapy after Campath-1H induction. Transplantation 2004; 78: 919.
27. Lee PC, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74: 1192.
28. Knechtle SJ. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients. Pediatr Transplant 2004; 8: 106.
29. Cecka JM, Gjertson DW, Terasaki PI. Pediatric renal transplantation: A review of the UNOS data. United Network for Organ Sharing. Pediatr Transplant 1997; 1: 55.
30. Dhanireddy KK, Maniscalco J, Kirk AD. Is tolerance induction the answer to adolescent non-adherence. Pediatr Transplant 2005; 9: 357.
31. Darenkov IA, Marcarelli MA, Basadonna GP, et al. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 1997; 64: 848.
32. Knechtle SJ, Fernandez LA, Pirsch JD, et al. Campath-1H in renal transplantation: The University of Wisconsin experience. Surgery 2004; 136: 754.
33. Malek SK, Obmann MA, Gotoff RA, et al. Campath-1H induction and the incidence of infectious complications in adult renal transplantation. Transplantation 2006; 81: 17.
34. Beaufigeau M, Dumesnil D, Carrier M, et al. Seven year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute. Transplant Proc 1997; 29: 10S.
35. Ellis D, Shapiro R, Jordan ML, et al. Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol 1994; 8: 193.
36. Tejani A, Fine R, Alexander S, et al. Factors predictive of sustained growth in children after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study. J Pediatr 1993; 122: 397.
37. Rosner B, Prineas R, Loggie J, Daniels SR. Percentiles for body mass index in U.S. children 5 to 17 years of age. J Pediatr 1998; 132: 211.